Showing 911-920 of 1148 results for "".
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN1206DementiaInsights-pdf/31235/CATIE-AD Study Reassesses Atypical Antipsychotics in Alzheimer’s DiseaseA recent analysis of the CATIE-AD (Clinical Antipsychotic Trials of Intervention Effectiveness in Alzheimer’s Disease) study challenges the efficacy and safety of atypical antipsychotic medications in managing behavioral symptom
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31300/Effective budgeting is a cornerstone of successful medical practices, including those in neurology, as highlighted by Craig T. Williams in the June 2006 issue of Practical Neurology. Williams emphasizes that creating, managing, and adhering to a realistic budget is essential for mitigating risks suc
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0406dementia-pdf/31324/Reevaluating the Amyloid Hypothesis in Alzheimer’s Disease: Are Current Approaches Misguided?In the April 2006 issue of *Practical Neurology*, Dr. David S. Geldmacher critically examines the prevailing amyloid hypothesis in the context of sporadic, late-onset Alzheimer’s disease (AD). The amyloid hy
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0306dementia-pdf/31333/Unintended Cognitive Effects of Anticholinergic Medications in Neurology PracticeAnticholinergic medications, widely prescribed for various conditions, pose significant cognitive risks, particularly in elderly patients and those with Alzheimer’s disease (AD). A community-based French study highlight
- Vascular Dementia: How to Solve the Puzzle of Cognitive Losshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn0905-vasculardementia-pdf/31405/Vascular Dementia: Multifaceted Etiologies and Clinical ImplicationsVascular dementia (VaD) encompasses a spectrum of cognitive impairments resulting from diverse cerebrovascular pathologies, challenging the notion of it being a singular condition. Unlike the earlier concept of multi-infarct dementi
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0405Dementia-pdf/31462/Diagnosing Alzheimer’s Disease: Balancing Compassion and AccuracyAlzheimer’s Disease (AD) remains a formidable challenge in neurology, not only due to its debilitating impact on patients but also because of the complexities surrounding its diagnosis and disclosure. Despite the progressive nature of
- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31470/The April 2005 issue of *Practical Neurology* addresses the increasing trend of generic substitution for antiepileptic drugs (AEDs) and the significant concerns it raises among healthcare professionals. While generic AEDs are not as widely substituted as other drug classes, their use is becoming mor
- Which Poses More Risk During Pregnancy: Seizure or AEDs?https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0305FeaPregnancy-pdf/31483/Managing Epilepsy During Pregnancy: Balancing Maternal and Fetal HealthEpilepsy affects approximately 1.1 million women of childbearing age in the United States, with three to five births per thousand involving women with this condition. As epilepsy requires long-term antiepileptic drug (AED) therap
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn0205pg24-25-pdf/31490/Hormone Replacement Therapy and Dementia Risk: Navigating Complex EvidenceThe intricate relationship between hormone replacement therapy (HRT) and cognitive function in postmenopausal women has been a subject of extensive research and debate. Initial epidemiological studies suggested that HRT, parti
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0608PainMgmnt-pdf/31018/Tailoring Chronic Pain Treatment to the PatientChronic pain remains a prevalent issue in the United States, affecting approximately 50 million individuals and imposing an economic burden of $85-90 billion annually. Defined as pain persisting beyond three months, chronic pain is considered maladaptiv